Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-82.27
Price to sales ratio
2.65
Dividends per share
0.32
Dividend yield %
1.77

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
6820
PEB-PF
Pebblebrook Hotel Trust 6.3% Series F Cumulative Redeemable Pre
20.29 USD0.00%+3.68%+1.40%+10.45%2.08 B USD
6837
RLJ-PA
RLJ Lodging Trust $1.95 Series A Cumulative Convertible Preferr
24.99 USD-0.16%+0.20%-1.58%+1.79%1.73 B USD
6931
INN-PF
Summit Hotel Properties Inc 5.875% Series F Cumulative Redeemab
16.67 USD+0.24%-0.77%-1.94%-5.28%708.71 M USD
6951
CLDT-PA
Chatham Lodging Trust (REIT) 6.625% Series A Cumulative Redeema
19.95 USD-0.15%-0.25%-2.06%-3.95%597.52 M USD

Frequently asked questions about Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab

What is the Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab stock price today?

The current price of Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab (INN-PE) is 17.61. Over the past 24 hours, the stock has changed by -0.51%. Follow the INN-PE chart for real-time price dynamics.

What is the stock ticker of Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab?

Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab trades under the ticker INN-PE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab stock going up?

INN-PE has changed by -0.45% over the last week, -0.73% over the last month, and -3.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab release financial reports?

Yes. You can track Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab net income for the last quarter?

Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab reported net income of -5.91 M for the last quarter. The previous quarter showed -2.58 M, which means net income changed by -129.45%.

How many employees does Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab have?

As of the latest available data, Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab has 78 employees. Workforce size can provide additional context about the company's scale and operations.

What is Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab EBITDA?

Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab EBITDA is 16.57 M, and its EBITDA margin is 8.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab stock?

You can buy Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab (INN-PE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab stock?

Investing in Summit Hotel Properties Inc 6.250% Series E Cumulative Redeemab requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INN-PE chart and related analysis on metatrader.com as part of your research.

News